Hikma Pharmaceutical | HIK - Ebitda


Hikma Pharmaceutical reported $369M in EBITDA for its fiscal semester ending in December of 2024.





Ebitda Change Date
Almirall EUR 114.07M 60.37M Dec/2025
argenx SE USD 404.12M 17.08M Dec/2025
AstraZeneca USD 5.67B 1.29B Mar/2026
Autolus Therapeutics Ltd USD -70.08M 11.23M Sep/2025
Bayer EUR 4.45B 2.49B Mar/2026
Fresenius EUR 951M 283M Mar/2026
Genmab DKK 186M 291M Dec/2025
GlaxoSmithKline GBP 2.77B 1.65B Mar/2026
GRIFOLS EUR 347.45M 210K Dec/2025
Hikma Pharmaceutical USD 369M 84M Dec/2024
Lakefront Biotherapeutics EUR -63.7M 624.2M Mar/2026
Lonza CHF 1.01B 54M Dec/2025
Merck EUR 1.53B 87M Mar/2026
Orion EUR 130.4M 212.6M Mar/2026
Recordati EUR 283.58M 36.43M Mar/2026
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 3.31B 3.65B Mar/2026
UCB EUR 1.6B 570M Dec/2025